PR71
POST REGISTRATION ACTION MAILED - SEC.71
07/07/2026
Voltar para busca
Dado oficial do USPTO
FUJIFILM TOYAMA CHEMICAL
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: Estados Unidos
Snapshot rápido
FUJIFILM TOYAMA CHEMICAL
ST13
US500000079262211Classe
5
Pedido
79262211
Registro
6087648
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
38
Atualização mais recente
07/07/2026
Tipo de marca
Verbal
Classes Nice
5
Data de depósito
03/04/2019
Data de registro
30/06/2020
Data de expiração
-
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
30/06/2020
Última transação
07/07/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
03
Localização do titular
JP
Examinador
BHUPATHI, TARA
Localização atual
Historical data usage
Titulares e representantes
Titulares
FUJIFILM Toyama Chemical Co., Ltd.
Representantes
Jeannine Rittenhouse IpHorgan Ltd
Classificação técnica
Classes Nice
Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical preparationspharmaceutical agents affecting central nervous systempharmaceutical agents affecting peripheral nervous systempharmaceutical agents affecting sensory organsantiallergic medicinescardiovascular agents for medical purposesagents affecting respiratory organspharmaceutical agents affecting digestive organshormones for medical purposesoxytocicsantihemorrhoidal preparationsemmenagoguesurinary tract disinfectantscontraceptive preparationspharmaceutical agents for epidermisvitamin preparations for medical purposesamino acid preparations for medical purposesroyal jelly for medical purposesorganotherapeuticsmineral preparations for medical purposesmedicinal alcoholanticoagulantsblood substitute for human useblood plasmahemostatics for medical purposespharmaceutical agents affecting metabolismcellular function activating agentstumor suppressing agentspharmaceutical agents for treating physically caused lesionspharmaceutical agents for treating chemically caused disordersantibiotic preparationschemotherapeuticsantitoxic seraantitoxinsvaccinespreparations for destroying parasitesdiagnostic preparations for medical purposesradio-isotope markers for therapeutic or diagnostic useprescription synthetic narcoticsveterinary vaccinesanti-infective products for veterinary useveterinary preparations for treatment of intestinal bacteria; preparations for destroying verminfungicidesherbicides; radioactive substances for medical purposes; reagent paper for medical purposes; oiled paper for medical purposes; drug delivery agents in the form of edible wafers for wrapping powdered pharmaceuticals; gauze for dressings; empty capsules for pharmaceuticals; eyepatches for medical purposes; ear bandages; menstruation bandages; menstruation tampons; sanitary napkins; sanitary panties; absorbent cottonabsorbent cotton pants for incontinence; adhesive plasters for medical purposes; bandages for dressings; breast-nursing pads; cotton swabs for medical use; dietary supplements for humans; dietetic beverages adapted for medical purposes; dietetic food adapted for medical purposes; dietary supplements for animals
Publicações
Histórico de despachos e eventos da marca no USPTO.
38 publicações encontradas
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
28/06/2026
ES71
TEAS SECTION 71 RECEIVED
06/03/2026
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
30/06/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
28/11/2024
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
05/12/2020
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
24/10/2020
XXCR
GENERIC MADRID TRANSACTION CREATED
23/10/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
30/09/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
30/06/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
14/04/2020
PUBO
PUBLISHED FOR OPPOSITION
14/04/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
25/03/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/03/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
11/03/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
11/03/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
11/03/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
11/03/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
19/02/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
19/02/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
19/02/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
19/02/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
19/02/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
19/02/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
19/02/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
19/02/2020
RFNT
REFUSAL PROCESSED BY IB
27/09/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
09/09/2019
RFRR
REFUSAL PROCESSED BY MPU
09/09/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
24/08/2019
CNRT
NON-FINAL ACTION WRITTEN
23/08/2019
RFWR
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
14/08/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
19/07/2019
CNRT
NON-FINAL ACTION WRITTEN
18/07/2019
MAFR
APPLICATION FILING RECEIPT MAILED
16/07/2019
DOCK
ASSIGNED TO EXAMINER
11/07/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/07/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
04/07/2019
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace FUJIFILM TOYAMA CHEMICAL ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.